Louise Burrell MD Profile
Louise Burrell MD

@LouiseBurrell3

Followers
478
Following
2K
Media
35
Statuses
458

Physician-scientist; Professor of Medicine, University of Melbourne; Long time cardiovascular 🫀 / ACE2 researcher; Opinions my own.

Melbourne, Victoria
Joined March 2013
Don't wanna be here? Send us removal request.
@DrAnoop_Koshy
Anoop Koshy
2 years
Congratulations to the brilliant @drThalysSR for an excellent oral presentation #CSANZ2023! You’ve been a privilege to supervise and mentor @LouiseBurrell3 @kaznegishi @thecsanz @Austin_Health @drchrisyu @HeartLungCirc @dralexcmurphy @DrJRamchand @INRanadive
0
1
20
@LouiseBurrell3
Louise Burrell MD
2 years
Wrong day to arrive in Italy !!
0
0
2
@AHajduczok
Alexander Hajduczok, MD 🇺🇦🙏
2 years
This might be the best thing I’ve ever seen - @NirUrielMD running a spin class, while giving a lecture on heart failure. One for the books for sure. @AbbottCardio @AlbertHicksMD @rcogswell_umn @DRJoycewald @davenport_clay @UlrichJordeMD @gtsayer @DrJennHaythe
73
276
2K
@dralexcmurphy
Alex Murphy
3 years
I am honoured to receive the @UniMelbMDHS Dean’s award for excellence. So many to thank but most importantly @drmatiasyudi @DrAnoop_Koshy @LouiseBurrell3 @Drroxmehran and the @Austin_Health community for making this dream a reality 💕#smartbreast #wic @WomenAs1 @VicWIC_au
4
2
34
@LouiseBurrell3
Louise Burrell MD
3 years
IBAS AGM- shout out to Bill Noonan , the previous CHair of tve Board- thank you ⁦@IBAS_Austin⁩ ⁦@Austin_Health
0
0
4
@Roxytonin
LaurieTomlinson
3 years
Ironically, our paper about real-world effects of COVID-19 medications is out today. Early in the roll-out of CMDUs there was relative equipoise and marked variation in treatment, enabling a robust comparison of sotrovimab and molnupiravir. https://t.co/gNqtTxXAiL
Tweet card summary image
bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients infected with...
3
20
42
@LouiseBurrell3
Louise Burrell MD
3 years
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
Tweet card summary image
bmj.com
Objective To determine whether disrupting the renin angiotensin system with angiotensin receptor blockers will improve clinical outcomes in people with covid-19. Design CLARITY was a pragmatic,...
0
0
2
@LouiseBurrell3
Louise Burrell MD
3 years
Very bad decision by the Fed Gov. Australian organisation offering independent advice on medicines is axed after funding is cut
Tweet card summary image
bmj.com
NPS MedicineWise, an Australian organisation offering independent and evidence based information on medicines, is to close at the end of 2022 after the federal government decided to cut its funding....
0
0
1
@KavurmaMary
Mary Kavurma
3 years
Without discovery research there are no medical breakthroughs, yet today we see a significant decline in funding for discovery researchers. There is no translation or advancement in knowledge without the discovery pipeline. https://t.co/9RgzoNvMwa @OzCvA @gemtreee @HRIAust
Tweet card summary image
cosmosmagazine.com
Heart disease remains our biggest killer – does the research funding it receives match its overall cost to the health system?
1
17
52
@jardine_meg
Meg Jardine @[email protected]
3 years
CLARITY on a clinically controversial question. Wonderful collaboration successfully completed during pandemic disruption. Publ BMJ wk Nov9 @vjha126 @SradhaKotwal @abhinavbassi @carinnahockham @TrialsCentre @GeorgeInstIN @LouiseBurrell3 #CarolPollock #ManyOthers #PatientPartners
1
3
6
@LouiseBurrell3
Louise Burrell MD
3 years
Security closed at t1 Mel airport- no reason given. But no flights departing.@Qantas
1
0
1
@ish2022
International Society of Hypertension 2022_Kyoto
3 years
Breaking News!📢 According to several sources, the Japanese government is making arrangements to facilitate entry into Japan. Travelers will be exempt from tourist visas if they receive 3rd vac or negative certificate. Prime Minister will make a final decision this week. @ISHBP
2
12
30
@LouiseBurrell3
Louise Burrell MD
3 years
Queen Elizabeth II, Britain’s longest-reigning monarch, dies aged 96
Tweet card summary image
theguardian.com
Death draws to a close Britain’s second Elizabethan era and heralds the reign of her son, King Charles III
0
0
2
@LouiseBurrell3
Louise Burrell MD
3 years
Really interesting results on the time you take your AHT meds on outcomes. TIME study- The Treatment in Morning versus Evening study. Thanks to Tom MacDonald for the study and discussion by @LabTouyz ESC Congress 2022 Barcelona | HOT LINE SESSION 1 https://t.co/QSJG1OlWdp ][p0
Tweet card summary image
esc365.escardio.org
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
0
0
4
@LouiseBurrell3
Louise Burrell MD
3 years
Great discussion by Dr Wang on publishing processes. A must listen to for ECRs. ESC Congress 2022 Barcelona | Highlights from circulation: arrhythmia and electrophysiology and new initiatives
Tweet card summary image
esc365.escardio.org
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
0
0
1
@LouiseBurrell3
Louise Burrell MD
3 years
Excellent session to kick off ESC- thank you ! ESC Congress 2022 Barcelona | The next frontiers in innovative therapies
Tweet card summary image
esc365.escardio.org
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
0
0
0
@LouiseBurrell3
Louise Burrell MD
3 years
Excellent presentation by Dr Alex Murphy in the Ralph Reader Prize Session @ CSANZ ⁦@dralexcmurphy⁩ ⁦@DrAnoop_Koshy⁩ ⁦@Austin_Health⁩ ⁦@UniMelbMDHS⁩ ⁦@DrJRamchand
0
1
12
@gemtreee
Prof Gemma Figtree AM
3 years
I am so invigorated and inspired by the amazing and emerging talent embedded across the #csanz2022 program @thecsanz with fresh clinically relevant discoveries that will benefit our patients. World-class meeting @ProfSNicholls @clara_chow @OzCvA @MonashHeart @CSHeartResearch
1
4
45
@FadiCharchar
Fadi Charchar
3 years
#Vaccines for #Heartdisease discussion @thecsanz 2022 meeting. @ISHR_AUS dream or the future?
0
2
8
@LouiseBurrell3
Louise Burrell MD
3 years
Excellent talk at CSANZ ⁦@thecsanz⁩ on CRISPR and heart disease ⁦@FadiCharchar
0
0
3